Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The update appears limited to minor formatting and a new update date, with no changes to the core study details (interventions, eligibility, outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:25:17.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T05:56:54.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Updated version tag to v3.1.0; removed explicit mention of an older revision v3.0.2. No other substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T03:14:01.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:53:20.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T16:54:44.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of publications related to a clinical study involving pembrolizumab and ibrutinib. Notably, previous references to certain location details and specific drug classifications have been removed.
    Difference
    6%
    Check dated 2025-08-31T12:09:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.